BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23334946)

  • 1. Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases.
    Conzo G; Pasquali D; Bellastella G; Esposito K; Carella C; De Bellis A; Docimo G; Klain M; Iorio S; Napolitano S; Palazzo A; Pizza A; Sinisi AA; Zampella E; Bellastella A; Santini L
    Endocrine; 2013 Oct; 44(2):419-25. PubMed ID: 23334946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.
    Conzo G; Docimo G; Pasquali D; Mauriello C; Gambardella C; Esposito D; Tartaglia E; Della Pietra C; Napolitano S; Rizzuto A; Santini L
    BMC Surg; 2013; 13 Suppl 2(Suppl 2):S3. PubMed ID: 24267409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
    Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
    Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
    Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
    World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of papillary thyroid carcinoma without lymph nodal involvement.
    Conzo G; Docimo G; Ruggiero R; Napolitano S; Palazzo A; Gambardella C; Mauriello C; Tartaglia E; Cavallo F; Santini L
    G Chir; 2012 Oct; 33(10):339-42. PubMed ID: 23095564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prophylactic central compartment lymph node dissection in elderly patients with differentiated thyroid cancer: a multicentric study.
    Gambardella C; Patrone R; Di Capua F; Offi C; Mauriello C; Clarizia G; Andretta C; Polistena A; Sanguinetti A; Calò P; Docimo G; Avenia N; Conzo G
    BMC Surg; 2019 Apr; 18(Suppl 1):110. PubMed ID: 31074400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer.
    Yoo D; Ajmal S; Gowda S; Machan J; Monchik J; Mazzaglia P
    World J Surg; 2012 Jun; 36(6):1255-61. PubMed ID: 22430670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: a retrospective study of a large clinical series.
    Conzo G; Calò PG; Sinisi AA; De Bellis A; Pasquali D; Iorio S; Tartaglia E; Mauriello C; Gambardella C; Cavallo F; Medas F; Polistena A; Santini L; Avenia N
    Surgery; 2014 Jun; 155(6):998-1005. PubMed ID: 24856120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective Central Compartment Lymph Node Dissection Does not Increase the Risk of Postoperative Hypoparathyroidism in Patients Treated for Differentiated Thyroid Cancer.
    Stubljar B; Pastorčić Grgić M; Mayer L; Perše P; Tomičević T
    Acta Clin Croat; 2020 Jun; 59(Suppl 1):115-121. PubMed ID: 34219893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
    So YK; Seo MY; Son YI
    Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma.
    Ahn JH; Kwak JH; Yoon SG; Yi JW; Yu HW; Kwon H; Kim SJ; Lee KE
    Surgery; 2022 Jan; 171(1):182-189. PubMed ID: 34391573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma.
    Moo TA; McGill J; Allendorf J; Lee J; Fahey T; Zarnegar R
    World J Surg; 2010 Jun; 34(6):1187-91. PubMed ID: 20130868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer is not cost-effective.
    Garcia A; Palmer BJ; Parks NA; Liu TH
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):754-61. PubMed ID: 24862564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
    Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
    Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prophylactic central neck dissection in clinically node-negative differentiated thyroid cancer: assessment of the risk of regional recurrence.
    Calò PG; Lombardi CP; Podda F; Sessa L; Santini L; Conzo G
    Updates Surg; 2017 Jun; 69(2):241-248. PubMed ID: 28409443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
    Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential Use of Total Thyroidectomy without Prophylactic Central Lymph Node Dissection for Early-Stage Papillary Thyroid Cancer: Oncologic Outcomes in an Integrated Health Plan.
    Said M; Fujimoto M; Franken C; Woo S; Vuong B; Haigh PI
    Perm J; 2016; 20(4):15-251. PubMed ID: 27723445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.
    Hughes DT; White ML; Miller BS; Gauger PG; Burney RE; Doherty GM
    Surgery; 2010 Dec; 148(6):1100-6; discussion 1006-7. PubMed ID: 21134539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.